Tokyo - Delayed Quote JPY

Ain Holdings Inc. (9627.T)

Compare
4,992.00 +55.00 (+1.11%)
At close: 3:45 PM GMT+9
Loading Chart for 9627.T
DELL
  • Previous Close 4,937.00
  • Open 4,963.00
  • Bid --
  • Ask --
  • Day's Range 4,902.00 - 4,992.00
  • 52 Week Range 4,282.00 - 6,285.00
  • Volume 102,300
  • Avg. Volume 85,822
  • Market Cap (intraday) 174.783B
  • Beta (5Y Monthly) 0.09
  • PE Ratio (TTM) 15.90
  • EPS (TTM) 314.00
  • Earnings Date Dec 6, 2024
  • Forward Dividend & Yield 160.00 (3.24%)
  • Ex-Dividend Date Apr 28, 2025
  • 1y Target Est 5,597.50

Ain Holdings Inc. engages in the dispensing pharmacy, and cosmetic and drug store businesses in Japan. The company's Dispensing Pharmacy segment operates dispensing pharmacies; sells generic drugs; and provides recruiting and consulting services. Its Cosmetic and Drug Store segment engages in the management of cosmetic and drug stores under the AINZ & TULPE brand name. The company's Other segment is involved in the retail store; and real estate leasing businesses. The company was formerly known as Ain Pharmaciez Inc. and changed its name to Ain Holdings Inc. in November 2015. Ain Holdings Inc. was incorporated in 1969 and is headquartered in Sapporo, Japan.

www.ainj.co.jp

11,474

Full Time Employees

April 30

Fiscal Year Ends

Recent News: 9627.T

View More

Performance Overview: 9627.T

Trailing total returns as of 11/25/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

9627.T
13.10%
Nikkei 225
15.89%

1-Year Return

9627.T
17.57%
Nikkei 225
15.33%

3-Year Return

9627.T
18.15%
Nikkei 225
31.46%

5-Year Return

9627.T
23.64%
Nikkei 225
66.49%

Compare To: 9627.T

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: 9627.T

View More

Valuation Measures

Annual
As of 11/22/2024
  • Market Cap

    172.86B

  • Enterprise Value

    130.98B

  • Trailing P/E

    15.89

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    0.42

  • Price/Book (mrq)

    1.28

  • Enterprise Value/Revenue

    0.32

  • Enterprise Value/EBITDA

    7.06

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    2.67%

  • Return on Assets (ttm)

    5.02%

  • Return on Equity (ttm)

    8.36%

  • Revenue (ttm)

    408.77B

  • Net Income Avi to Common (ttm)

    10.9B

  • Diluted EPS (ttm)

    314.00

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    49.4B

  • Total Debt/Equity (mrq)

    4.36%

  • Levered Free Cash Flow (ttm)

    --

Research Analysis: 9627.T

View More

Company Insights: 9627.T

Research Reports: 9627.T

View More

People Also Watch